EN
HI
Beryl Drugs Share price
BERLDRG
22
0.75 (-3.30%)Last updated on 8 Oct, 2025 | 15:17 IST
BUYSELL
Today's High
23.25
Today's Low
22.00
52 Week Low
17.35
52 Week High
46.00
The current prices are delayed, login to your account for live prices
LoginBeryl Drugs Share Key Metrics
Volume
1167.00
Market Cap
11.54 CR
LTQ@LTP
20@22.00
ATP
22.71
Var Margin
100 %
Circuit Range
18.2-27.3
Delivery %
0 %
Value
26502.57
ASM/GSM
No
Market Lot
1
Beryl Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
37.73
Sector P/B
3.6
Sec. Div. Yield
0.55
Beryl Drugs Resistance and Support
Pivot 19.16
Resistance
First Resistance
19.57
Second Resistance
20.31
Third Resistance
20.72
Support
First Support
18.42
Second Support
18.01
Third Support
17.27
Beryl Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2025-09-02 | A.G.M. |
| 2025-08-07 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Beryl Drugs News
About Beryl Drugs
NSE : 0
BSE : 524606
ISIN : INE415H01017
Beryl Drugs Management
| Name | Position |
|---|---|
| Mr. Sudhir Sethi | Chairman & Director |
| Mr. Sanjay Sethi | Managing Director |
Beryl Drugs Similar Stocks
Bacil Pharma Ltd.
43.33
-0.53 (1.21%)
Ishita Drugs & Industries Ltd.
74.39
0.38 (0.51%)
Emmessar Biotech & Nutrition Ltd.
31.99
0.15 (0.47%)
Saroja Pharma Industries India Ltd.
0.00
0.00 (0.00%)
Starsource Multitrade Ltd.
134.70
13.00 (10.68%)
Link Pharma Chem Ltd.
35.50
0.50 (1.43%)
Sharma East India Hospitals & Medical Research Ltd
142.60
-2.90 (1.99%)
Clinitech Laboratory Ltd.
41.71
-2.19 (4.99%)
Beryl Drugs FAQs
The Buying Price of Beryl Drugs share is 22 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Beryl Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beryl Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Beryl Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Beryl Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Beryl Drugs’s valuation compare Sector P/E, P/B which are 37.73 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Beryl Drugs is 11.54 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Beryl Drugs share price is 46.00 & 17.35. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Beryl Drugs belongs to the Healthcare sector.